firstly, to be deemed a "competitive" product you'd assume they're marketed and commercially produced for treatments.
secondly, why must the question be the quality of OTC products? the percentages? if they have 10%, 15%, 40%, CBD,it's irrelevant. OTC products aren't completely dependent on CBD either. it's a combination of factors, that's one (active) ingredient you're targeting. if one product have optimised their results with 10% CBD and the other 60%, it doesn't matter. you don't fix concentrations to draw relevant comparisons on effectiveness or target concentration to the superficial skin layers.
thirdly ... why? they have 3 separate products for this.
fourthly ... NO. OTC products are relevant seeing that's the active ingredient. that was the point of the 3rd party analysis.
Criticism is obviously welcome. just don't think your points are completely accurate .... good thoughts nevertheless!
(20min delay)